Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 35  |  Issue : 2  |  Page : 722-727

Ketorolac use and postoperative complications in colorectal surgery


Department of General Surgery, Faculty of Medicine, Menoufia University, Menoufia, Egypt

Correspondence Address:
Mohammed S. A. Ahmed
Department of General Surgery, Faculty of Medicine, Menoufia University, Menoufia
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_265_21

Rights and Permissions

Objective To determine if use of intravenous ketorolac in the perioperative period for colorectal surgeries is associated with higher rates of reinterventions, emergency-department (ED) visits, and readmissions. Background Injectable NSAIDs, such as ketorolac, have been shown to have an equivalent analgesic effect to morphine in major abdominal surgery and reduce the use of opioid medications. However, NSAIDs have corresponding adverse reactions, mainly on the gastrointestinal tract, and cardiovascular, liver, and kidney injury. Patients and methods A clinical trial study was carried out on 50 adult patients who had undergone colorectal surgery in General Surgery Department in Menoufia University and Damanhur Medical National Institute, that aimed to determine if use of intravenous ketorolac in the perioperative period for colorectal surgeries is associated with higher rates of reinterventions, ED visits, and readmissions during the period from March 2019 to March 2021. Results Type of operation, duration of operation, and first bowel motion showed significant differences between patients with and without ketorolac in the first bowel motion. While no significant difference was found between both groups regarding outcome. The ketorolac group was associated with higher ED visits (K: 16% vs. no K: 12%), higher rates of readmission (K: 12% vs. no K: 8%), and equal rates of reintervention (K: 4% vs. no K: 4%) with no statistically significant differences between patients with and without ketorolac. However, rates of anastomotic leakage in relation to use of ketorolac during the postoperative period for the ketorolac group show that 4% used ketorolac for 3–5 days and 8% used ketorolac for more than 5 days, it shows statistically significant rates of anastomotic leakage with longer duration of ketorolac use. Conclusion Ketorolac as one of the most commonly used NSAIDS was not associated with anastomotic leak or other important postoperative outcomes, however, overuse of ketorolac over a long period may lead to increased rates of anastomotic leakage or postoperative bleeding. Recognizing the significant benefit of ketorolac, its appropriate use in the postoperative period appears safe.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1373    
    Printed20    
    Emailed0    
    PDF Downloaded87    
    Comments [Add]    

Recommend this journal